Omri Amirav-Drory - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Omri Amirav-Drory’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- E-commerce,
- Disruptive Innovation,
- Wellness,
- Enterprise Software,
- Fundraising,
- Customer Engagement,
- Business Model Innovation,
- Community Development,
- Cryptocurrency,
- Marketplace Platforms,
- Startups,
- Venture Fundraising,
- Mobile,
- Finance,
- Software,
- Manufacturing,
- Biotechnology,
- Creative Industry,
- Entrepreneurship,
- Gaming,
- Games,
- FinTech,
- Disruptive technology,
- Digital Transformation,
- Space Technology,
- Consumer Internet,
- Consumer Software,
- Agriculture,
- Insurance,
- Generative Tech/AI,
- SaaS,
- Information Technology,
- B2B,
- Digital Assets,
- Machine Learning,
- Pharmaceuticals
Social media:
Past investments:
- Wild Biotech
- EdiTy Therapeutics
- Light Bio, Inc.
- Armada Biosystems
- Powerhouse Biology
- Permanence Bio
- Immunai
- Mana.bio
- Eleven Therapeutics
- Mammoth Biosciences
- Renewal Bio
- La Jolla Labs
- Talus Bio
- Pumpkinseed
- ZipBio
- Pangea Therapeutics
- PsygaBio
- Cyclana Bio
- Centivax
- ImmuneBridge
- TwoStep Therapeutics
- Gilboa Therapeutics
- resistanceBio
- Radar Therapeutics
- Loop Genomics
- C2i Genomics
- Nanocarry Therapeutics
- Pepper Bio
- Twist Bioscience
Investor Profile
Omri Amirav-Drory is a Venture Capital, Private Equity Firm, Angel/Individual based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Wild Biotech, EdiTy Therapeutics, Light Bio, Inc., Armada Biosystems, Powerhouse Biology, Permanence Bio, Immunai, Mana.bio, Eleven Therapeutics, Mammoth Biosciences, Renewal Bio, La Jolla Labs, Talus Bio, Pumpkinseed, ZipBioPangea Therapeutics, PsygaBio, Cyclana Bio, Centivax, ImmuneBridge, TwoStep Therapeutics, Gilboa Therapeutics, resistanceBio, Radar Therapeutics, Loop Genomics, C2i Genomics, Nanocarry Therapeutics, Pepper Bio, Twist Bioscience, . Over time, Omri Amirav-Drory has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Omri Amirav-Drory is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, E-commerce, Disruptive Innovation, Wellness, Enterprise Software, Fundraising, Customer Engagement, Business Model Innovation, Community Development, Cryptocurrency, Marketplace Platforms, Startups, Venture Fundraising, Mobile, Finance, Software, Manufacturing, Biotechnology, Creative Industry, Entrepreneurship, Gaming, Games, FinTech, Disruptive technology, Digital Transformation, Space Technology, Consumer Internet, Consumer Software, Agriculture, Insurance, Generative Tech/AI, SaaS, Information Technology, B2B, Digital Assets, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Omri Amirav-Drory, as their portfolio suggests a familiarity and interest in this area.
Understanding Omri Amirav-Drory’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
